(Press-News.org)
Homologous Recombination Deficiency (HRD) is a biomarker that predicts ovarian cancer treatment with PARP inhibitors or breast cancer treatment with first-line platinum-based chemotherapy. However, limited research is documented on platinum-based treatment prediction with HRD as a biomarker in ovarian cancer patients, especially in the Chinese population.
This first-ever China prospective cohort study, jointly conducted by BGI Genomics clinical researcher Dr. Shao Di and the Fudan University Shanghai Cancer Center team and published on the Journal of Ovarian Research indicates that HRD testing can accurately predict the sensitivity of platinum-based chemotherapy for ovarian cancer patients.
Research Method
The study covered 240 patients with primary treatment of high-grade serious ovarian cancer (HGSOC) admitted to the Cancer Hospital of Fudan University from January 2016 to September 2018 interval. Patients received more than two cycles of platinum-containing adjuvant chemotherapy after surgery and were classified as platinum-sensitive (Pt) and platinum-resistant according to the time of ovarian cancer recurrence.
All patients were tested with a gene panel test screening for 68 HRR genes, to assess the mutation status of HRR-related genes such as BRCA. Of these, 118 samples underwent the HRD test to assess loss of heterozygosity (LOH), telomere allele disequilibrium (TAI), and large segmental recombination abnormality (LST) status. The Kaplan-Meier method was used to plot survival curve and the effectiveness of these tests in predicting patient outcomes.
Results
Out of 240 HGSOC patients enrolled in the study, 82.5% had Pt-sensitive cancer with a platinum-free interval of more than six months. The study shows that 31.2% of patients had BRCA gene mutations, 53 in BRCA1 and 22 in BRCA2 (Figure 1). Additionally, 25% of patients had mutations in non-BRCA/HRR genes.
The proportion of patients with positive HRD status was 64.4%. Such results reveal that, compared to Western population, a higher proportion of Chinese ovarian cancer patients benefit from PARP inhibitor maintenance therapy.
HRR gene mutation and HRD status are highly correlated with platinum chemotherapy sensitivity in patients with HGSOC.
Findings showed that the HRD score of platinum treatment-sensitive patients was slightly higher than that of Pt-resistant patients (Figure 2A).
Further analysis also found that the rate of Pt-sensitive patients in the HRD+ BRCAm group and HRD+ BRCAwt group was significantly higher than that in the HRD-BRCAwt group (Figure 2B).
Similarly, the study also found that Pt-sensitive patients were more enriched in the BRCA mutation group and non-BRCA HRR mutation group than HRR wt group.
Analysis showed that patients with positive HRD status had a significantly longer progression-free survival (PFS) compared to those with negative HRD status (median PFS: 30.5 months vs 16.8 months, p=0.001 - Fig.3A).
Conclusion
This study demonstrated for the first time that HRD is a valid biomarker tool for predicting sensitivity to platinum-based chemotherapy in prospective cohort unselected Chinese ovarian cancer patients.
The study also found a higher rate of HRD positivity in Chinese ovarian cancer patients than in Western populations, suggesting that HRD testing could screen a higher proportion of Chinese PARP inhibitor population to facilitate precision therapy.
About BGI Genomics
BGI Genomics, headquartered in Shenzhen China, is the world’s leading integrated solutions provider of precision medicine. Our services cover over 100 countries and regions, involving more than 2,300 medical institutions. In July 2017, as a subsidiary of BGI Group, BGI Genomics (300676.SZ) was officially listed on the Shenzhen Stock Exchange.
END
“Ted brings a wealth of knowledge and expertise in virology and human immune responses to viruses. He has played a key role in developing antiviral vaccines and furthering our understanding of important viruses transmitted by mosquitoes and ticks—arboviruses—and how neutralizing antibodies work against flaviviruses, such as Zika virus,” said Acting NIAID Director Hugh Auchincloss, M.D. “He is exceptionally well-suited to lead the VRC and its continued pursuit of innovative basic, translational and clinical discovery.”
Prior to his VRC appointment, Dr. Pierson served as a senior investigator and chief of NIAID’s Laboratory of ...
Brain Canada, Heart & Stroke, and the Canadian Stroke Consortium are thrilled to announce the recipients of the 2022 Stroke Clinical Research Catalyst Grants. The purpose of this program is to increase capacity for clinical stroke research within Canada, with an aim to reduce the burden of stroke, prevent recurrence, and improve patient outcomes through clinical research that will improve our understanding of stroke and advance stroke care.
“We are thrilled to be collaborating with two leading organizations ...
Gaithersburg, MD; April 25, 2023 - Cartesian Therapeutics, a fully integrated biopharmaceutical company pioneering RNA cell therapy for autoimmune diseases and cancer, today announced the appointment of three world-renowned scientists and engineers as charter members of the company’s Scientific Advisory Board (SAB): Prof. Jennifer Elisseeff (Johns Hopkins University), Prof. Andrés García (Georgia Institute of Technology), and Prof. David Mooney (Harvard University).
“These distinguished research leaders bring vast ...
A new class of immunotherapy shows promising results for fighting the most aggressive form of skin cancer.
The study, published today in Nature Communications by researchers from King’s College London and Guy’s and St Thomas’ NHS Foundation Trust, investigates whether a novel antibody can target and treat melanomas. The results show that the antibody activates the immune response to fight cancer and slows melanoma growth in mice.
Malignant melanoma is the most aggressive type of skin cancer with poor ...
What is shyness? Research has shown that shyness is characterized by fear and nervousness in response to social novelty and/or social evaluation. Shyness can manifest on behavioral, affective, and physiological levels, but little is known about how these components cluster. Longstanding theories note that shyness may be conceptualized as a trait that is relatively stable across development, which is described as temperamental shyness. Shyness may also be conceptualized as an emotion that is felt in a certain social situation, which is described as state shyness. To ...
Research shows that given the difficulties in navigating social relationships, children with more autistic traits might be prone to less attuned self-conscious emotions after transgression (displaying less guilt and embarrassment and more shame). A new study released in Child Development by researchers at Vrije Universiteit and the University of Amsterdam investigated for the first time the association between autistic traits and self-conscious emotions of guilt, embarrassment, and shame in young children.
Researchers also further examined ...
Social drinking after work is traditionally seen as an important way to build relationships in East Asia. There’s sometimes even a fear that missing out could leave you on the back foot when climbing the career ladder. However, a joint paper looking at the drinking habits and economic situation of working men in Japan, Taiwan and South Korea has found that those who can drink more do not seem to have a financial leg-up over their alcohol-intolerant and less-drinking colleagues. As almost half of the population in East Asia has some intolerance to alcohol, and with the growth of the sober-curious lifestyle, this result may come as good news to those ...
Raman imaging offers a greater potential for detecting multiple enzyme activities than fluorescence imaging, demonstrate Tokyo Tech researchers by developing 9CN-rhodol-based activatable Raman probes using a novel mechanism for Raman signal activation. The strategy allows a synthesis of highly activatable Raman probes with high aggregation and multiplexing ability, making it a promising tool for extending the range of Raman probes for the detection of multiple enzyme activities in heterogeneous biological tissues.
The involvement of enzymes in a wide range of biological activities makes them ideal biomarkers for the detection of diseases. In fact, ...
In Japan, many municipalities have suffered from population decline due to low birth rates and an aging population. In 2022, the Japanese population over the age of 65 was 36.21 million, accounting for 28.9% of the total population. In addition, approximately 1,300 shrinking cities are within the 1,700 municipalities in Japan. Moreover, the large number of shrinking cities in Japan is unprecedented on a global scale. As a response to the low birthrate, the Japanese government is discussing “unprecedented” measures to reverse the decline, such as ...
A new Cochrane Review led by an Upstate Medical University professor has found that, compared with standard antibiotic treatment, stool transplantation can increase the number of people recovering from Clostridioides difficile (C. diff) infection, a condition which causes potentially life-threatening diarrhea. 77 percent of people who received a stool transplant did not experience reinfection within eight weeks, compared to 40 percent of those who received antibiotics alone.
C. diff is a bacterium that can cause life-threatening diarrheal illness in individuals ...
